Verastem, Inc. (VSTM) intrinsic value & 10-year financials

Verastem, Inc. (VSTM) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 2.1% a year to $30.9M, with an average return on invested capital of 89.1%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$8.65
Market cap
$599.5M
Revenue (FY2025)
$30.9M
Revenue growth (10-yr CAGR)
2.1%
ROIC (10-yr avg)
89.1%
Free cash flow (FY2025)
—

VSTM 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $30.9M -$209.5M -$3.02 — -550.3% 274.0%
FY2024 $10.0M -$130.6M -$1.83 -$104.8M -1149.6% 407.9%
FY2023 — -$87.4M -$1.97 — — -942.7%
FY2022 $2.6M -$73.8M -$0.00 — -2809.6% -217.6%
FY2021 $2.1M -$71.2M -$0.00 -$53.7M -2991.2% -103.2%
FY2020 $88.5M -$67.7M -$0.00 -$33.5M -55.8% -561.8%
FY2019 $17.5M -$149.2M -$0.00 -$138.5M -758.1% 402.9%
FY2018 $26.7M -$72.4M -$0.00 -$76.0M -354.8% 980.8%
FY2017 — -$67.8M -$0.00 — — 701.6%
FY2016 — -$36.4M -$0.00 -$29.5M — -50.4%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Verastem, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Verastem, Inc. has historically struggled to out-earn its cost of capital, averaging just -14.3% ROIC.

Over the decade, Verastem, Inc. shows that management has aggressively returned capital to shareholders by retiring 99.6% of outstanding shares.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Verastem, Inc. is modeled at 2.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-33.14 per share.

VSTM stock: frequently asked questions

What is the intrinsic value of Verastem, Inc. (VSTM) stock?

Graham's formula only works with positive earnings. Verastem, Inc. reported diluted EPS of -$3.02 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

What is VSTM's return on invested capital?

Average ROIC over the last 10 fiscal years was 89.1%, and average return on equity was -331.6%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this VSTM data come from?

From Verastem, Inc.'s annual 10-K filings on SEC EDGAR. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks